Author: JT Smith
AMIDiag for Linux, the latest version of AMI’s industry standard diagnostic software, is being developed in a 100% native Linux environment. AMIDiag for Linux supports all major Linux distributions including those from Redhat, SuSE and Mandrake. The product provides a structured diagnostic environment that is ideal for embedded Linux applications.
In addition to AMIDiag for Linux, American Megatrends offers a complete line of diagnostic utilities including AMIDiag for DOS, Windows and AMIDiag for the Extensible Firmware Interface (EFI). With the addition of AMIDiag for Linux to the line of AMIDiag utilities, American Megatrends offers the most complete solution available.
“With an estimated growth of 154% in Linux systems, it is a necessity to offer a diagnostic solution which supports the open source community,” said Stefano Righi, Engineering Director, Diagnostic Utilities. “AMIDiag for Linux will allow AMI to continue its mission in providing the most advanced products to its customers.”
AMIDiag for Linux is set to release in the fourth quarter of 2001. Prior to its release to the market, AMIDiag for Linux will undergo an extensive beta-testing program. Users who are interested in participating should check www.ami.com for more news and updates on the program.
About AMI
Founded in 1985, American Megatrends Inc. (AMI) has dedicated its resources to providing OEMs, resellers and systems integrators with leading edge computer technologies. This privately held company, best known for its Basic Input/Output Systems or BIOS, also supplies its state-of-the-art hardware, software, utilities and RAID controllers to over 55 percent of today?s high-tech manufacturers. Headquartered in Atlanta, AMI has locations in the U.S. and throughout the world including Munich, London, Taipei, Chennai, Seoul and Tokyo to better serve our customers. For more information on AMI, its products, services or reseller opportunities, call 1-800-U-BUY-AMI or visit www.ami.com.
###
All registered trademarks are property of their respective companies.